CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
China CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir, Find details about China Ledipasvir, Ledipasvir Powder from CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder API Ledipasvir
Basic Info.
Model NO.
D-sung Ledipasvir
Product Name
Ledipasvir
Name
Ledipasvir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti HCV
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1256388-51-8
Mf
C49h54f2n8o6
MW
889.00
Density
1.42±0.1 (20 Oc 760 Torr)
Storage
Normal
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Model NO.
D-sung Ledipasvir
Product Name
Ledipasvir
Name
Ledipasvir Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Anti HCV
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
1256388-51-8
Mf
C49h54f2n8o6
MW
889.00
Density
1.42±0.1 (20 Oc 760 Torr)
Storage
Normal
Trademark
D-sung
Transport Package
Negotiable
Specification
99%
Origin
Shaanxi Xi′an
Product Desciption
CAS 1256388-51-8 Anti HCV Ledipasvir Material Ledipasvir Powder Api Ledipasvir
| Product name | Ledipasvir |
| Cas number | 1256388-51-8 |
| Appearance | White powder |
| MF | C49H54F2N8O6 |
| MW | 889.00 |
Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C, it is an inhibitor of the hepatitis C virus NS5A protein. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.
Ledipasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, ledipasvir is indicated for the treatment of HCV genotypes 1, 4, 5, and 6. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV.
Ledipasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, ledipasvir is indicated for the treatment of HCV genotypes 1, 4, 5, and 6. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV.
You Might Also Like
Lattice Bar Decoration Thermal Break Aluminum Sliding Doors
Refurbished iPhone 6 Smart Phone 64GB
body-building machine, Gym Equipment, Fitness Equipment- Pec......
16L Agriculture Electric Sprayer Knapsack Sprayer Gf- 16b -0......
Bulk Price CAS 183133 -96-2 Cabazitaxel for Preventing Prost......
Jhk Decorative Strip Composite Finger Joint House Plank Flus......
Medical Biosafety Transport Box, Transport Box
Good Price for 50W Solar Street Light for 5 Years Warranty
Professional Manufacturer of Water Chiller 100kw~800kw Air C......
Sz- 4003b Wireless Bt Game Controller Gamepad PC Game Joysti......
Factory Supply Non-Inductive High Power Thick Film Reisistor......